"RPLND is an attractive option for those who prefer to avoid chemotherapy," write Jiping Zeng, MD; Timothy A. Masterson, MD; and Clint Cary, MD, MPH, MBA.
Clint Cary, MD, MBA, MPH
Advertisement
Articles by Clint Cary, MD, MBA, MPH
Advertisement
Latest Updated Articles
The role of surgery continues to evolve in seminomaPublished: September 24th 2024 | Updated:
Advertisement
Advertisement
Trending on Urology Times
1
ORIC-944 shows promise in combination with ARPIs for mCRPC
2
Jason Hafron, MD, recaps prostate cancer data from ESMO 2025
3
Beyond PSA: Jonathan Henderson, MD, on precision tools for prostate cancer
4
Radioligands and ADT alternatives emerge in prostate cancer treatment
5
